Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - methysergide maleate; methysergide 1mg (as maleate) -

Malta - English - Medicines Authority

alliance pharmaceuticals limited avonbridge house, bath road, chippenham, wiltshire sn15 2bb, united kingdom - methysergide maleate - tablet - methysergide maleate 1.33 mg - analgesics

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - methysergide maleate 1.33mg (as hydrogen maleate = 1mg methysergide base) - tablet - 1 mg - active: methysergide maleate 1.33mg (as hydrogen maleate = 1mg methysergide base) excipient: acacia carnauba wax colloidal silicon dioxide gelatin ink lactose monohydrate maize starch maleic acid purified talc   stearic acid sucrose titanium dioxide

Canada - English - Health Canada

novartis pharmaceuticals canada inc - methysergide maleate - tablet - 2mg - methysergide maleate 2mg - sympatholytic (adrenergic blocking) agents

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ergometrine maleate, quantity: 500 microgram/ml - injection, solution - excipient ingredients: maleic acid; water for injections - prophylaxis ergometrine is administered after the delivery of the placenta for the purpose of contracting the uterus in order to prevent postpartum haemorrhage and postabortion haemorrhage due to uterine atony. treatment ergometrine is administered after the delivery of the placenta to promote involution of the uterus in order to treat postpartum haemorrhage and postabortion haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - oxytocin, quantity: 5 iu; ergometrine maleate, quantity: 0.5 mg - injection, solution - excipient ingredients: sodium chloride; maleic acid; water for injections; acetic acid; sodium acetate trihydrate; chlorobutanol hemihydrate - active management of the third stage of labour. prevention and treatment of post-partum haemorrhage associated with uterine atony.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - methysergide maleate - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - methysergide maleate - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - methysergide maleate - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - methysergide maleate - oral tablet - 1mg